Abstract
Background: High-risk neuroblastoma is the most frequent extra-cranial solid tumor in childhood, and is faced with poor prognosis despite intensive therapy. Allogeneic stem cell transplantation in combination with adoptive recipient leukocyte infusion (RLI) has been proposed as a potentially promising new strategy, and has already been shown to be effective in murine neuroblastoma models.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
